期刊文献+

壳聚糖/硫酸葡聚糖/重组人骨形态发生蛋白-2微球诱导异位成骨的实验研究 被引量:2

Ectopic osteogenesis induced by microspheres of chiston/dextran sulfate/recombinant human bone morphogenetic protein-2
原文传递
导出
摘要 【摘要】目的探讨壳聚糖/硫酸葡聚糖/重组人骨形态发生蛋白-2(CS/DS/rhBMP-2)异位诱导成骨能力。方法将48只SD大鼠随机分为4组,制作大鼠左大腿股四头肌肌袋模型,分别将明胶海绵、CS/DS微球、rhBMP-2和CS/DS/rhBMP.2微球适当压缩后分别植入股四头肌肌袋肌间隙中,并于4、8、12、16周后取材行苏木精-伊红(HE)染色、碱性磷酸酶(ALP)活性与钙含量检测;植入后第16周行X线片检查。结果①组织学切片:植入后第4周,4组均无明显骨组织形成;植入后第8周,CS/DS/rhBMP-2微球组可见少量骨细胞、骨髓,骨小梁转化为成熟的骨质,骨小梁间有骨髓腔和骨髓样物质形成;rhBMP-2组可见少量骨小梁及骨细胞,骨细胞周围见少量成骨细胞及软骨细胞,但骨组织不及CS/DS/rhBMP-2微球组成熟。植入后第12、16周,rhBMP-2组和CS/DS/rhBMP-2微球组均有成熟的骨组织形成,骨小梁中可见骨陷窝,骨陷窝中有骨细胞,骨细胞周围有大量成骨细胞。但CS/DS/rhBMP-2微球组骨组织较rhBMP-2组成熟,骨陷窝及骨小梁量均多于rhBMP.2组;明胶海绵组及CS/DS微球组无明显骨组织形成。②ALP活性及钙含量检测:除第4周外,第8、12、16周CS/DS/rhBMP-2组纳米微球的ALP活性及钙含量均高于rhBMP-2组,差异有统计学意义(P〈0.05)。(3)X线检查:植入后第16周,CS/DS/rhBMP.2微球组及rhBMP-2组植入部位均有X线不透性物质,密度较均匀,CS/DS/rhBMP.2微球组阻射密度与周围股骨接近,rhBMP-2组阻射密度较周围股骨稍低,CS/DS/rhBMP-2微球组高密度区面积明显较rhBMP-2组大,明胶海绵组及CS/DS微球组无高密度组织形成。结论CS/DS/rhBMP-2复合微球异位成骨能力较单独rhBPM-2强,可能有助于CS/DS/rhBMP-2复合微球在骨组织工程领域的应用。 Objective To explore the capacity of microspheres of chiston/dextran sulfate/recom- binant human bone morphogenetic protein-2 (CS/DS/rhBMP-2) to induce ectopic osteogenesis. Methods Quadriceps muscle bags were created at the left legs in 48 SD rats which were randomly divided into 4 groups. Gelatin sponge, CS/DS, rhBMP-2 and CS/DS/rhBMP-2 microspheres were implanted into the muscle bags of the 4 groups respectively. At 4, 8, 12 and 16 weeks after implantation, samples were har- vested for examinations of histology by hematoxylin-eosin (HE) staining, alkaline phosphatase (ALP) activity and calcium content. An X-ray check was done at the 16th weekend. Results At 4 weeks, no obvious bone tissue formed in the 4 groups. At 8 weeks, in CS/DS/rhBMP-2 group, a small number of bone cells were observed, bone marrow formed, trabecular bone turned into mature sclerotin, and bone marrow and bone-like materials formed between the trabecular bones. In rhBMP-2 group, some trabecular bone and bone cells were seen, there were a small number of osteoblasts and chondrocytes around the bone cells, but the bone tissues were less mature than in CS/DS/rhBMP-2 group. At 12 and 16 weeks in CS/DS/rhBMP-2 and rhBMP-2 groups, mature bone tissues were seen, and on bone pits in trabecular bone there were bone cells around which a large number of osteoblasts appeared. The bone tissues in CS/DS/rhBMP-2 group were more mature than in rhBMP-2 group, and there were more bone lacunas and bone trabeculae in CS/DS/rhBMP-2 group. No obvious bone tissues formed in gelatin sponge or CS/DS groups. At 8, 12 and 16 weeks, the ALP activity and calcium content in CS/DS/rhBMP-2 group were significantly higher than in rhBMP-2 group (P 〈 0. 05). X-ray check at 16 weeks revealed radio-opaque substance with uniform density at the implantation sites in both CS/DS/rhBMP-2 and rhBMP-2 groups. The radiation density of CS/DS/rhBMP-2 microspheres was close to that of nearby femur while the radiation density of rhBMP-2 microspheres was lower than that of nearby femur. The high density radiation area in CS/DS/rhBMP-2 group was larger than in rhBMP-2 group. No high density tissues formed in gelatin sponge or CS/DS group. Conclusion Since CS/DS/rhBMP-2 microspheres are more capable of inducing ectopic bone formation than rhBPM-2 ones, they may have a promising prospect of application in bone tissue engineering.
出处 《中华创伤骨科杂志》 CAS CSCD 北大核心 2015年第7期616-623,共8页 Chinese Journal of Orthopaedic Trauma
基金 国家自然科学基金(51303031) 广东省自然科学基金项目(S2012010009743) 广东省科技计划项目(2013J4100120)
关键词 骨形态发生蛋白质类 壳聚糖 硫酸葡聚糖 骨化 异位 Bone morphogenetic proteins Chitosan Dextran sulfate Ossification, hetero- topic
  • 相关文献

参考文献3

二级参考文献34

  • 1Cui X, Zhang B, Wang Y, et al.Effects of ehitosan-eoated pressed caleium sulfate pellet combined with recombinant human bone morphoganetie protein 2 on restoration of segmental bonedefeetJ Craniofae Surg, 2008, 2:459-465.
  • 2Hirma I, Nomura Y, It O M, el aLAceeleration of bone formation with BMP2 in frame-reinforced carbonate apatite-collagen sponge scaffolds.J Artif Organs, 2007, 4:212-217.
  • 3Patel ZS, Yamamoto M, Ueda H, etal. Biodegradable gelatin mieropartieles as delivery systems for the controlled release of bone morpbogenetie protein-2.Aeta Biomater, 200B, 5:1126-1138.
  • 4Wang AH, Chen XG, Liu CS, et al. Preparation and characteristics of chitosan microspheres in different acetylation as drug carrier system.J Microencap Sul, 2008, 24:1-10.
  • 5Guliyeva U, Oner F, Ozsoy S, et M. Chitosan microparticles containing plasmid DNA as potential oral gene delivery system.Eur J Pharm Biopharm,2006,62(1): 17-25.
  • 6Muzzarelli R. Biochemical significance of exogenous ehitins and ehitosans in animals and patients, Carbohyd Polym, 1993,20 : 7 -16.
  • 7Tang ZX, Qian JQ, Shi LE. Preparation of ehitosan nanoparticles as carrier for immobilized enzyme.Appl Biochem Biotechnol,2007,136 (1):77-96.
  • 8Ozbas TS, Akbuga J, Aral C.Controlhd release of interleukin-2 from ehitosan mierosphere.J Pharm Sei, 2002, 5:1245-1251.
  • 9Zheng AP,Wang JC,Lu WL,et al.Thymopentin-loadod pH-sensitive ehitosan nanopartieles for oral administration: preparation, characterization and pharmaeodynamies.J Nanosei Nanoteehnol, 2006,6 : 2936-2944.
  • 10Cheburu CN, Stoica B, Neamtu A, et al. Bioeompatibility testing of chitosan hydroge|s[J]. Rev Med Chir Soc Med Nat Iasi, 2010, 115: 864-870.

共引文献16

同被引文献14

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部